AJNN
Academic Journal of Neuropsychiatry and Psychology

Academic Journal of Neuropsychiatry and Psychology (formerly known as the Academic Journal of Neurology and Neurosurgery, e-ISSN:3023-6517), deals with neurology, neurosurgery, psychiatry and clinical psychology accepts articles on these topics. Academic Journal of Neuropsychiatry and Psychology publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
Gut microbiome modulation through non-pharmacological therapy in psychiatric disorders: neurotransmitter synthesis, neuroplasticity, and brain-gut signaling
Abstract
Psychiatric disorders affect over 970 million people globally, with substantial personal, social, and economic costs that continue to rise despite advances in treatment. Current pharmacological approaches show limited efficacy for many patients, with significant side effects and high discontinuation rates. The integration of microbiome science with psychiatric research offers new perspectives on disease etiology, biomarker development, and therapeutic intervention. Recent advances in microbiome research reveal that the gut microbiome directly synthesizes neurotransmitters and their precursors, while microbial metabolites produced by the microorganisms through their metabolic activities, cross the blood-brain barrier (BBB) to influence regulate microglial activation, synaptic plasticity, neurogenesis, and neural circuit development associated with our brain’s function. Specific gut bacterial taxa demonstrate causal relationships with psychiatric symptoms through vagal, immune, and metabolic pathways. Gut dysbiosis patterns consistently emerge across major psychiatric conditions associated with distinct microbial signatures. Scientific research has discovered that disrupted circadian rhythm and dysregulated stress response system especially the hypothalamic pituitary adrenal (HPA) axis both disrupt gut microbiota composition and function, leading to health issues like metabolic syndrome, gastrointestinal disorders, and mental wellness issues. Understanding these mechanisms opens unprecedented opportunities for non-pharmacological approaches that integrate microbiome analysis and targeted interventions. The authors of this article aim to explore how non-pharmacological intervention methods such as mental wellness behavioral therapy and educational therapy can be integrated with gut microbiome knowledge to enhance patient outcomes, focusing on mental health, gastrointestinal, and metabolic disorders.

Keywords : Educational therapy, mental wellness behavioral therapy, gut-brain axis, microbial metabolites, neurotransmitter synthesis, neuroplasticity, psychiatric disorders

Download Article


1. Salvadori M, Rosso G. Update on the gut microbiome in health and diseases. World J Methodol. 2024;14(1):89196. doi:10.5662/wjm.v14.i1.89196
2. Sharma B, Kumar A, Sharma U, Pal D, Prashar S. The potential role of gut microbiota in the pathogenesis of type 2 diabetes mellitus via epigenetics and inflammasome. Endocr Metab Immune Disord Drug Targets. 2022;22(14):1331-1343. doi:10.2174/1871530322666220331152809
3. Glinert A, Turjeman S, Elliott E, Koren O. Microbes, metabolites and (synaptic) malleability, oh my! The effect of the microbiome on synaptic plasticity. Biol Rev Camb Philos Soc. 2022;97(2):582-599. doi:10.1111/brv.12812
4. Dash S, Syed YA, Khan MR. Understanding the role of the gut microbiome in brain development and its association with neurodevelopmental psychiatric disorders. Front Cell Dev Biol. 2022;10: 880544. doi:10.3389/fcell.2022.880544
5. Fock E, Parnova R. Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids. Cells. 2023;12(4):657. doi:10. 3390/cells12040657
6. Sarkar A, Harty S, Johnson KV, et al. The role of the microbiome in the neurobiology of social behaviour. Biol Rev Camb Philos Soc. 2020;95(5): 1131-1166. doi:10.1111/brv.12603
7. Singh H, Chopra C, Singh H, et al. Gut-brain axis and Alzheimer’s disease: Therapeutic interventions and strategies.J Functional Foods. 2024;112:105915. doi:10.1016/j.jff.2023.105915
8. Ma L, Wang HB, Hashimoto K. The vagus nerve: an old but new player in brain-body communication. Brain Behav Immun. 2025;124:28-39. doi:10.1016/j.bbi.2024.11.023
9. Magalhães HIR, Castelucci P. Enteric nervous system and inflammatory bowel diseases: correlated impacts and therapeutic approaches through the P2X7 receptor. World J Gastroenterol. 2021;27(46):7909-7924. doi: 10.3748/wjg.v27.i46.7909
10. Sharkey KA, Mawe GM. The enteric nervous system. Physiol Rev. 2023; 103(2):1487-1564. doi:10.1152/physrev.00018.2022
11. Mayer EA, Nance K, Chen S. The gut-brain axis. Annu Rev Med. 2022; 73:439-453. doi:10.1146/annurev-med-042320-014032
12. Yassin LK, Nakhal MM, Alderei A, et al. Exploring the microbiota-gut-brain axis: impact on brain structure and function. Front Neuroanat. 2025;19:1504065. doi:10.3389/fnana.2025.1504065
13. Zang Y, Lai X, Li C, Ding D, Wang Y, Zhu Y. The role of gut microbiota in various neurological and psychiatric disorders-an evidence mapping based on quantified evidence. Mediators Inflamm. 2023;2023:5127157. doi:10.1155/2023/5127157
14. Dicks LMT. Gut bacteria and neurotransmitters. Microorganisms. 2022;10(9):1838. doi:10.3390/microorganisms10091838
15. De Sales-Millán A, Aguirre-Garrido JF, González-Cervantes RM, Velázquez-Aragón JA. Microbiome-gut-mucosal-immune-brain axis and autism spectrum disorder (ASD): a novel proposal of the role of the gut microbiome in ASD aetiology. Behav Sci (Basel). 2023;13(7):548. doi:10.3390/bs13070548
16. Wong GC, Montgomery JM, Taylor MW. The gut-microbiota-brain axis in autism spectrum disorder. In: Grabrucker AM, editor. Autism Spectrum Disorders [Internet]. Brisbane (AU): Exon Publications; 2021. doi:10.36255/exonpublications.autismspectrumdisorders.2021.gutmicrobiota
17. Boehme M, Rémond-Derbez N, Lerond C, et al. Bifidobacterium longum subsp. longum reduces perceived psychological stress in healthy adults: an exploratory clinical trial.Nutrients.2023;15(14):3122. doi:10.3390/nu15143122
18. Alatan H, Liang S, Shimodaira Y, et al. Supplementation with Lactobacillus helveticus NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression. Front Immunol. 2024;15:1407620. doi:10.3389/fimmu.2024.1407620
19. Boustany A, Feuerstadt P, Tillotson G. The 3 Ds: depression, dysbiosis, andClostridiodes difficile. Adv Ther. 2024;41:3982-3995 doi:10.1007/s12325-024-02972-0
20. Dunlop BW, Cha J, Mayberg HS, et al. Association of bile acids with connectivity of executive control and default mode networks in patients with major depression. bioRxiv [Preprint]. 2024:2024.12.20.629637. doi: 10.1101/2024.12.20.629637
21. Dziedzic A, Maciak K, Blizniewska-Kowalska K, Galecka M, Kobierecka W, Saluk J. The power of psychobiotics in depression: a modern approach through the microbiota-gut-brain axis: a literature review. Nutrients. 2024;16(7):1054. doi:10.3390/nu16071054
22. Giuliano G, Benedetti S, Sambo M, Pierguidi F, Tumbarello M. Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy. Clin Microbiol Infect. 2024;30(4):556-557. doi:10.1016/j.cmi.2024.01.008
23. Ioannou M, Borkent J, Andreu-Sánchez S, et al. Reproducible gut microbial signatures in bipolar and schizophrenia spectrum disorders: a metagenome-wide study. Brain Behav Immun. 2024;121:165-175. doi: 10.1016/j.bbi.2024.07.009
24. Khaledi M, Sameni F, Gholipour A, et al. Potential role of gut microbiota in major depressive disorder: a review. Heliyon. 2024;10(12):e33157. doi: 10.1016/j.heliyon.2024.e33157
25. Nirmalkar K, Patel J, Kang DW, et al. (2024). Bimodal distribution of intestinal Candidain children with autism and its potential link with worse ASD symptoms.Gut Microbes Reports.2024;1(1):2358324. doi:10.1080/29933935.2024.2358324
26. Rishi P, Kaur A, Kaur H. COVID-19 Pandemic and Mental Illness: Impact of Gut Microbiota. In: Sobti, R.C., Dhalla, N.S., Watanabe, M., Sobti, A. (eds) Delineating health and health system: mechanistic insights into COVID 19 complications. Springer, Singapore. 2021. doi: 10.1007/978-981-16-5105-2_20
27. Xu J, Zhou L, Chen Z, et al.Bacilluscoagulans and Clostridium butyricum synergistically alleviate depression in a chronic unpredictable mild stress mouse model through altering gut microbiota and prefrontal cortex gene expression. Front Pharmacol. 2024;15: 1393874. doi:10.3389/fphar.2024.1393874
28. Zhang L, Shao Y, Li Y, et al. Epidemiological and molecular investigations of sequential outbreaks of Campylobacter jejuni infecting adults and schoolchildren in Southeastern China, 2021-2022. Int J Infect Dis. 2024;144:107055. doi:10.1016/j.ijid.2024.107055
29. Zhao J, Liu J, Feng J, Liu X, Hu Q. The gut microbiota-brain connection: insights into major depressive disorder and bipolar disorder. Front Psychiatry. 2024;15:1421490. doi:10.3389/fpsyt.2024.1421490
30. Levine BH, Hoffman JM. Gut microbiome transplants and their health impacts across species. Microorganisms. 2023;11(6):1488. doi:10.3390/microorganisms11061488
31. Levkova M, Chervenkov T, Pancheva R. Genus-level analysis of gut microbiota in children with autism spectrum disorder: a mini review. Children (Basel). 2023;10(7):1103. doi:10.3390/children10071103
32. Lewandowska-Pietruszka Z, Figlerowicz M, Mazur-Melewska K. Microbiota in autism spectrum disorder: a systematic review. Int J Mol Sci. 2023;24(23):16660. doi:10.3390/ijms242316660
33. Li H, Liu C, Huang S, et al. Multi-omics analyses demonstrate the modulating role of gut microbiota on the associations of unbalanced dietary intake with gastrointestinal symptoms in children with autism spectrum disorder. Gut Microbes. 2023;15(2):2281350. doi:10.1080/19490976. 2023.2281350
34. Ramirez Garcia A, Greppi A, Constancias F, et al. Anaerobutyricum hallii promotes the functional depletion of a food carcinogen in diverse healthy fecal microbiota.Frontiers in Microbiomes.2023;2:1194516. doi: 10.3389/frmbi.2023.1194516
35. Rashnaei N, Akhavan Sepahi A, Siadat SD, Shahsavand-Ananloo E, Bahramali G. Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls. Front Cell Infect Microbiol. 2023;13:1233687. doi:10.3389/fcimb.2023.1233687
36. Tamés H, Sabater C, Margolles A, Ruiz L, Ruas-Madiedo P. Production of GABA in milk fermented by Bifidobacterium adolescentis strains selected on the bases of their technological and gastrointestinal performance. Food Res Int. 2023;171:113009. doi:10.1016/j.foodres.2023. 113009
37. Daneberga Z, Nakazawa-Miklasevica M, Berga-Svitina E, et al. Urinary organic acids spectra in children with altered gut microbiota composition and autistic spectrum disorder. Nord J Psychiatry. 2022; 76(7):523-529. doi:10.1080/08039488.2021.2014954
38. Elwakil BH, Bakr BA, Aljeldah MM, et al. Memory impairment, pro-inflammatory host response and brain histopathologic severity in rats infected withK. pneumoniaeorP. aeruginosa meningitis. Pathogens. 2022;11(8):933. doi:10.3390/pathogens11080933.
39. Gkougka D, Mitropoulos K, Tzanakaki G, et al. Gut microbiome and attention deficit/hyperactivity disorder: a systematic review. Pediatr Res. 2022;92(6):1507-1519. doi:10.1038/s41390-022-02027-6
40. Glover JS, Browning BD, Ticer TD, Engevik AC, Engevik MA. Acinetobacter calcoaceticusis well adapted to withstand intestinal stressors and modulate the gut epithelium. Front Physiol. 2022;13: 880024. doi:10.3389/fphys.2022.880024
41. Kakabadze E, Makalatia K, Bakuradze N, et al. (2022). Gut health of children with autism spectrum disorder. World Academy Sci J. 2022;4: 29. doi:10.3892/wasj.2022.164
42. Liu Q, Mak JWY, Su Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022; 71(3):544-552. doi:10.1136/gutjnl-2021-325989.
43. Raghavan K, Dedeepiya VD, Yamamoto N, et al. Benefits of gut microbiota reconstitution by beta 1,3-1,6 glucans in subjects with autism spectrum disorder and other neurodegenerative diseases.J Alzheimer’s Disease. 2022;94(s1):S241-S252. doi:10.3233/JAD-220388
44. Son J, Baritugo KA, Sohn YJ, et al. Production of ?-aminobutyrate (GABA) in recombinantcorynebacterium glutamicumby expression of glutamate decarboxylase active at neutral pH. ACS Omega. 2022;7(33): 29106-29115. doi:10.1021/acsomega.2c02971
45. Zhang F, Zhou Y, Chen H, et al. Curcumin alleviates DSS-induced anxiety-like behaviors via the microbial-brain-gut axis. Oxid Med Cell Longev. 2022;2022:6244757. doi:10.1155/2022/6244757
46. Agarwala S, Naik B, Ramachandra NB. Mucosa-associated specific bacterial species disrupt the intestinal epithelial barrier in the autism phenome. Brain Behav Immun Health. 2021;15:100269. doi:10.1016/j.bbih.2021.100269
47. Elwishahy A, Antia K, Bhusari S, Ilechukwu NC, Horstick O, Winkler V. Porphyromonas gingivalisas a risk factor to Alzheimer’s disease: a systematic review. J Alzheimers Dis Rep. 2021;5(1):721-732. doi:10.3233/ADR-200237
48. Ezeji JC, Sarikonda DK, Hopperton A, et al.Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health. Gut Microbes. 2021;13(1):1922241. doi:10.1080/19490976.2021.1922241
49. Jeong J, Lee Y, Yoon S, Kim JH, Kim W. Lactiplantibacillus plantarum LRCC5314 includes a gene for serotonin biosynthesis via the tryptophan metabolic pathway. J Microbiol. 2021;59(12):1092-1103. doi:10.1007/s12275-021-1472-2
50. Knuesel T, Mohajeri MH. The role of the gut microbiota in the development and progression of major depressive and bipolar disorder. Nutrients. 2021;14(1):37. doi:10.3390/nu14010037
51. Szopinska-Tokov J, Dam S, Naaijen J, et al. Investigating the gut microbiota composition of individuals with attention-deficit/hyperactivity disorder and association with symptoms. Microorganisms. 2020;8(3):406. doi:10.3390/microorganisms8030406
52. Zuffa S, Schimmel P, Gonzalez-Santana A, et al. Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder. Transl Psychiatry. 2023;13(1):257. doi:10.1038/s41398-023-02556-6
53. Jayapala HPS, Lim SY. N-3 polyunsaturated fatty acids and gut microbiota. Comb Chem High Throughput Screen. 2023;26(5):892-905. doi:10.2174/1386207325666220701121025
54. Matsumura Y, Kitabatake M, Kayano SI, Ito T. Dietary phenolic compounds: their health benefits and association with the gut microbiota. Antioxidants (Basel). 2023;12(4):880. doi:10.3390/antiox12040880
55. Salminen A. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota. J Mol Med (Berl). 2023;101(3):201-222. doi:10.1007/s00109-023-02289-5
56. Zhao X, Kong M, Wang Y, et al. Nicotinamide mononucleotide improves the Alzheimer’s disease by regulating intestinal microbiota. Biochem Biophys Res Commun. 2023;670:27-35. doi:10.1016/j.bbrc.2023.05.075
57. O’Riordan KJ, Collins MK, Moloney GM, et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572. doi:10.1016/j.mce.2022.111572
58. Yan Z, Yang F, Sun L, et al. Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson’s disease: an animal study. Brain Behav Immun. 2022;106:307-321. doi:10.1016/j.bbi.2022.09.009
59. Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021;20:301-319. doi:10.17179/excli2020-3239
60. Sokolovskaya OM, Shelton AN, Taga ME. Sharing vitamins: Cobamides unveil microbial interactions. Science. 2020;369(6499):eaba0165. doi:10. 1126/science.aba0165
61. Recharla N, Geesala R, Shi XZ. Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review. Nutrients. 2023;15(10):2275. doi:10.3390/nu15102275
62. Wise JL, Cummings BP. The 7-?-dehydroxylation pathway: an integral component of gut bacterial bile acid metabolism and potential therapeutic target. Front Microbiol. 2023;13:1093420. doi:10.3389/fmicb.2022.1093420
63. Kiriyama Y, Nochi H. Role of microbiota-modified bile acids in the regulation of intracellular organelles and neurodegenerative diseases. Genes (Basel). 2023;14(4):825. doi:10.3390/genes14040825
64. Aljeradat B, Kumar D, Abdulmuizz S, et al. Neuromodulation and the gut-brain axis: therapeutic mechanisms and implications for gastrointestinal and neurological disorders. Pathophysiology. 2024; 31(2):244-268. doi:10.3390/pathophysiology31020019
65. Aizawa S, Uebanso T, Shimohata T, Mawatari K, Takahashi A. Effects of the loss of maternal gut microbiota before pregnancy on gut microbiota, food allergy susceptibility, and epigenetic modification on subsequent generations. Biosci Microbiota Food Health. 2023;42(3):203-212. doi:10.12938/bmfh.2022-093
66. Scardaci R, Manfredi M, Barberis E, Scutera S, Marengo E, Pessione E. Serotonin exposure improves stress resistance, aggregation, and biofilm formation in the probiotic Enterococcus faecium NCIMB10415. Microbiology Research.2021;12(3):606-625. doi:10.3390/microbiolres 12030043
67. Iorizzo M, Paventi G, Di Martino C. Biosynthesis of gamma-aminobutyric acid (GABA) byLactiplantibacillus plantarumin fermented food production. Curr Issues Mol Biol. 2023;46(1):200-220. doi:10.3390/cimb46010015
68. Agnihotri N, Mohajeri MH. Involvement of intestinal microbiota in adult neurogenesis and the expression of brain-derived neurotrophic factor. Int J Mol Sci. 2022;23(24):15934. doi:10.3390/ijms232415934
69. Anbalagan S. Endocrine cross-talk between the gut microbiome and glial cells in development and disease. J Neuroendocrinol. 2021;33(5): e12924. doi:10.1111/jne.12924
70. Missiego-Beltrán J, Beltrán-Velasco AI. The role of microbial metabolites in the progression of neurodegenerative diseases-therapeutic approaches: a comprehensive review. Int J Mol Sci. 2024; 25(18):10041. doi:10.3390/ijms251810041
71. Martinelli, A. Sustainable promotion of mental health and prevention of mental health disorders across the world. In: Rezaei, N. (eds) Integrated Science for Sustainable Development Goal 3. Integrated Science, vol 25. Springer, Cham. 2024. doi:10.1007/978-3-031-64288-3_1
72. GDB (Global Burden of Disease) Study: Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137-150. doi:10.1016/S2215-0366(21)00395-3
73. Mitrea L, Nemeş SA, Szabo K, Teleky BE, Vodnar DC. Guts imbalance imbalances the brain: a review of gut microbiota association with neurological and psychiatric disorders. Front Med (Lausanne). 2022;9: 813204. doi:10.3389/fmed.2022.813204
74. McGuinness AJ, Davis JA, Dawson SL, et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry. 2022; 27(4):1920-1935. doi:10.1038/s41380-022-01456-3
75. Puricelli C, Rolla R, Gigliotti L, et al. The gut-brain-immune axis in autism spectrum disorders: a state-of-art report. Front Psychiatry. 2022; 12:755171. doi:10.3389/fpsyt.2021.755171
76. Numakawa T, Kajihara R. An interaction between brain-derived neurotrophic factor and stress-related glucocorticoids in the pathophysiology of Alzheimer’s disease. Int J Mol Sci. 2024;25(3):1596. doi:10.3390/ijms25031596
77. Kielbik P, Witkowska-Pilaszewicz O. The relationship between canine behavioral disorders and gut microbiome and future therapeutic perspectives. Animals (Basel). 2024;14(14):2048. doi:10.3390/ani14142048
78. Versele R, Sevin E, Gosselet F, Fenart L, Candela P. TNF-? and IL-1ß modulate blood-brain barrier permeability and decrease amyloid-ß peptide efflux in a human blood-brain barrier model. Int J Mol Sci. 2022;23(18):10235. doi:10.3390/ijms231810235
79. Grebenciucova E, VanHaerents S. Interleukin 6: at the interface of human health and disease. Front Immunol. 2023;14:1255533. doi:10. 3389/fimmu.2023.1255533
80. Rusch JA, Layden BT, Dugas LR. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Front Endocrinol (Lausanne). 2023;14:1130689. doi:10.3389/fendo.2023.1130689
81. Hoffman KW, Lee JJ, Corcoran CM, Kimhy D, Kranz TM, Malaspina D. Considering the microbiome in stress-related and neurodevelopmental trajectories to schizophrenia. Front Psychiatry. 2020;11:629. doi:10.3389/fpsyt.2020.00629
82. Jacobs JP, Gupta A, Bhatt RR, et al. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome. 2021;9(1):236. doi:10.1186/s40168-021-01188-6
83. Gutierrez DE, Lashinger LM, Weinstock GM, Bray MS. Circadian rhythms and the gut microbiome synchronize the host’s metabolic response to diet. Cell Metab. 2021;33(5):873-887. doi:10.1016/j.cmet. 2021.03.015
84. Samanta S, Bagchi D. An intricate relationship between circadian rhythm dysfunction and psychiatric diseases. Explor Neurosci. 2024;3: 321-351. doi:10.37349/en.2024.00053
85. Tran L, Shaikh M, Engen PA, et al. Impact of peripheral circadian misalignment and alcohol on the resiliency of intestinal barrier and microbiota. Gut Microbes. 2025;17(1):2509281. doi:10.1080/19490976.2025. 2509281
86. Common Comorbidities with Substance Use Disorders Research Report. Bethesda (MD): National Institutes on Drug Abuse (US); April 2020.
87. Campêlo SR, Barbosa MA, Porto CC, Dias DR. Prevalence of comorbid substance use disorders with anxiety disorders or post-traumatic stress disorder in people seeking treatment for substance abuse: a systematic review protocol. JBI Evid Synth. 2021;19(8):1924-1933. doi:10.11124/JBIES-20-00267
88. Martinez JE, Kahana DD, Ghuman S, et al. Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome. Front Endocrinol (Lausanne). 2021;12: 667066. doi:10.3389/fendo.2021.667066
89. Chen H, Cao T, Zhang B, Cai H. The regulatory effects of second-generation antipsychotics on lipid metabolism: potential mechanisms mediated by the gut microbiota and therapeutic implications.Front Pharmacol. 2023;14:1097284. doi:10.3389/fphar.2023.1097284
90. Dias MF, Nogueira YJA, Romano-Silva MA, Marques de Miranda D. Effects of antipsychotics on the gastrointestinal microbiota: a systematic review.Psychiatry Res. 2024;336:115914. doi:10.1016/j.psychres.2024.115914
91. Misera A, Loniewski I, Palma J, et al. Clinical significance of microbiota changes under the influence of psychotropic drugs. An updated narrative review. Front Microbiol. 2023;14:1125022. doi:10.3389/fmicb. 2023.1125022
92. Biazzo M, Deidda G. Fecal microbiota transplantation as new therapeutic avenue for human diseases. J Clin Med. 2022;11(14):4119. doi:10.3390/jcm11144119
93. Cronin P, Joyce SA, O’Toole PW, O’Connor EM. Dietary fibre modulates the gut microbiota.Nutrients. 2021;13(5):1655. doi:10.3390/nu13051655
94. Gill SK, Rossi M, Bajka B, Whelan K. Dietary fibre in gastrointestinal health and disease.Nat Rev Gastroenterol Hepatol. 2021;18(2):101-116. doi:10.1038/s41575-020-00375-4
95. Perrone P, D’Angelo S. Gut microbiota modulation through mediterranean diet foods: implications for human health. Nutrients. 2025;17(6):948. doi:10.3390/nu17060948
96. Singh TP, Natraj BH. Next-generation probiotics: a promising approach towards designing personalized medicine. Crit Rev Microbiol. 2021; 47(4):479-498. doi:10.1080/1040841X.2021.1902940
97. Zandifar A, Badrfam R, Mohammaditabar M, et al. The effect of prebiotics and probiotics on levels of depression, anxiety, and cognitive function: a meta-analysis of randomized clinical trials.Brain Behav. 2025;15(3):e70401. doi:10.1002/brb3.70401
98. Strain R, Stanton C, Ross RP. Effect of diet on pathogen performance in the microbiome. Microbiome Res Rep. 2022;1(2):13. doi:10.20517/mrr. 2021.10
99. Yadav MK, Kumari I, Singh B, Sharma KK, Tiwari SK. Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Appl Microbiol Biotechnol. 2022;106(2):505-521. doi:10.1007/s00253-021-11646-8
100. Chua CK, Chia KH. A brief review of educational therapy and its current role: part 1. Unlimited Human. 2023;4-5. doi:10.5281/zenodo.15219971
101. Toader C, Dobrin N, Costea D, et al. Mind, mood and microbiota-gut-brain axis in psychiatric disorders.Int J Mol Sci. 2024;25(6):3340. doi: 10.3390/ijms25063340
102. Sanada K, Montero-Marin J, Alda Díez M, et al. Effects of mindfulness-based interventions on salivary cortisol in healthy adults: a meta-analytical review. Front Physiol. 2016;7:471. doi:10.3389/fphys.2016.00471
103. Aguilar-Raab C, Stoffel M, Hernández C, et al. Effects of a mindfulness-based intervention on mindfulness, stress, salivary alpha-amylase and cortisol in everyday life. Psychophysiology. 2021;58(12):e13937. doi:10. 1111/psyp.13937
104. Nesbitt AD. Delayed sleep-wake phase disorder.J Thorac Dis. 2018; 10(Suppl 1):S103-S111. doi:10.21037/jtd.2018.01.11
105. Sun SY, Chen GH. Treatment of circadian rhythm sleep-wake disorders. Curr Neuropharmacol. 2022;20(6):1022-1034. doi:10.2174/1570159X 19666210907122933
106. Trompeter N, Bussey K, Forbes MK, Mitchison D. (2021). Emotion dysregulation within the CBT-E model of eating disorders: a narrative review. Cognitive Therapy and Research. 2021;45(6):1021-1036. doi:10. 1007/s10608-021-10225-5
107. Malik K, Ibrahim M, Bernstein A, et al. Behavioral activation as an ‘active ingredient’ of interventions addressing depression and anxiety among young people: a systematic review and evidence synthesis.BMC Psychol. 2021;9(1):150. doi:10.1186/s40359-021-00655-x
108. Di Sante J, Akeson B, Gossack A, Knäuper B. Efficacy of ACT-based treatments for dysregulated eating behaviours: a systematic review and meta-analysis.Appetite. 2022;171:105929. doi:10.1016/j.appet.2022. 105929
109. Chang C, Fraga J. How grief upsets your gut health. Time. 2022. Available: https://time.com/6193214/grief-gut-health/?utm_source=chatgpt.com
110. Khajuria A, Kumar A, Joshi D, Kumaran SS. Reducing stress with yoga: a systematic review based on multimodal biosignals.Int J Yoga. 2023; 16(3):156-170. doi:10.4103/ijoy.ijoy_218_23
111. van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev. 2018;38:3-16. doi:10.1016/j.smrv.2017.02.001
112. BaHammam AS, Pirzada A. Timing matters: the interplay between early mealtime, circadian rhythms, gene expression, circadian hormones, and metabolism-a narrative review. Clocks Sleep. 2023;5(3):507-535. doi:10.3390/clockssleep5030034
113. Kosanovic Rajacic B, Sagud M, Pivac N, Begic D. Illuminating the way: the role of bright light therapy in the treatment of depression. Expert Rev Neurother. 2023;23(12):1157-1171. doi:10.1080/14737175.2023.2273396
114. Chunduri A, Reddy SDM, Jahanavi M, Reddy CN. Gut-brain axis, neurodegeneration and mental health: a personalized medicine perspective. Indian J Microbiol. 2022;62(4):505-515. doi:10.1007/s12088-022-01033-w
115. Williams, N. PHQ-9.Occupational Medicine.2014;64(2):139-140. doi: 10.1093/occmed/kqt154
116. Williams, N. (2014b). The GAD-7 questionnaire.Occupational Medicine. 2014;64(3):224. doi:10.1093/occmed/kqt161
117. Camilleri M. Fifty-point IBS-SSS responders but persistence of moderate severity IBS in over 40% of those on diet.Gut. 2022. doi:10. 1136/gutjnl-2022-328211
118. Tripathi A, Das A, Kar SK. Biopsychosocial model in contemporary psychiatry: current validity and future prospects.Indian J Psychol Med. 2019;41(6):582-585. doi:10.4103/IJPSYM.IJPSYM_314_19
119. Chia KH, Tan MK, Loi CTT. Re-examining the controversial case of ‘autistic enterocolitis’: the role of gut-brain xis in autism spectrum disorder. ISRG J Clin Med Medical Res. 2025;2(3):1-11. doi:10.5281/zenodo.15335311
120. Grant AD, Erfe MCB, Delebecque CJ, et al. Lactiplantibacillus plantarum Lp815 decreases anxiety in people with mild to moderate anxiety: a direct-to-consumer, randomised, double-blind, placebo-controlled study. Benef Microbes. 2025;16(5):521-532. doi:10.1163/ 18762891-bja00073
Article available in :
Volume 2, Issue 4, 2025
Page : 68-81
https://doi.org/10.51271/AJNN-0037
Article Information
Received : 27 Eyl 2025
Accepted : 18 Ara 2025
Published : 31 Ara 2025
Corresponding Author :

Meng-Kiat Tan: Merlion Paediatric Therapy Clinic, Singapore

[email protected]
Citation : Tan MK, Chia KH. Gut microbiome modulation through non-pharmacological therapy in psychiatric disorders: neurotransmitter synthesis, neuroplasticity, and brain-gut signaling. Acad J Neurol Neurosurg. 2025;2(4):68-81.

Read: 202
Download : 212
Cited: 0
_Footer